Integra LifeSciences Holdings (IART)

Sector:Health Care
Super Investor Stats:
Ownership count:2
Ownership rank:348
% of all portfolios:0.016%
Hold Price * :$25.09
History Portfolio Manager Activity Share change % change to portfolio
Q3  2024
Robert Olstein - Olstein Capital Management Add 37.17% 42,000 0.13
Q2  2024
Robert Olstein - Olstein Capital Management Add 13.00% 13,000 0.07
Meridian Contrarian Fund Buy 148,000 0.82
Q1  2024
Lee Ainslie - Maverick Capital Add 8.87% 767 0.00
Robert Olstein - Olstein Capital Management Add 35.14% 26,000 0.15
Q4  2023
Lee Ainslie - Maverick Capital Add 15.85% 1,184 0.00
Robert Olstein - Olstein Capital Management Add 4.23% 3,000 0.02
Q3  2023
Robert Olstein - Olstein Capital Management Add 2.90% 2,000 0.01
Q2  2023
Robert Olstein - Olstein Capital Management Add 53.33% 24,000 0.16
Q1  2023
Lee Ainslie - Maverick Capital Add 65.76% 4,029 0.00
Q4  2022
Lee Ainslie - Maverick Capital Buy 6,127 0.01
Q3  2022
Robert Olstein - Olstein Capital Management Add 2.22% 1,000 0.01
Q2  2022
Robert Olstein - Olstein Capital Management Add 7.14% 3,000 0.02
Q4  2021
Robert Olstein - Olstein Capital Management Add 9.76% 4,000 0.03
Q2  2021
Lee Ainslie - Maverick Capital Add 126.34% 12,447 0.01
Q4  2020
Robert Olstein - Olstein Capital Management Add 6.98% 3,000 0.03
Q3  2020
Lee Ainslie - Maverick Capital Buy 20,892 0.02
Robert Olstein - Olstein Capital Management Add 19.44% 7,000 0.06
Q2  2020
Robert Olstein - Olstein Capital Management Add 13.53% 4,290 0.04
Q1  2020
Robert Olstein - Olstein Capital Management Add 51.00% 10,710 0.10
Q4  2019
Robert Olstein - Olstein Capital Management Add 133.33% 12,000 0.11
Q3  2019
Robert Olstein - Olstein Capital Management Add 12.50% 1,000 0.01
Q2  2019
Robert Olstein - Olstein Capital Management Buy 8,000 0.07

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.